DCS, the Region A recovery audit contractor covering the Northeast, has overturned its automated reviews of untimed codes, according to a notice on the DCS website.
The Latest
A random survey of claims by the Medicare Part B carrier in five states has uncovered average error rates of 50-90 percent for E/M codes, according to a report by Part B News.
AZ West Endoscopy Center, a new endoscopy ASC under development in Phoenix has an exciting opportunity for an experienced Administrator/Nurse Manager for a new center opening this summer. Aside from responsibilities listed below, this person will be integral in assisting…
Lynn S. Feldman, RN, MBA, administrative manager of Eastwind Surgical, a spine center in Westerville, Ohio, discusses eight reimbursement and business concepts for spine.
Here are 10 statistics about orthopedic-driven ambulatory surgery centers, defined here as ASCs that perform greater than 50 percent orthopedics. Data comes from VMG Health's Multi-Specialty ASC Intellimarker 2010. All figures are averages.
A patient's expectation of a drug's effect influences the drug's efficacy and the pain-related brain pathways that are activated during treatment, according to a study published in Science Translational Medicine.
Weight-loss surgery centers can expect an increase in surgeries, following a decision by the Food and Drug Administration to expand the use of Lap-Band, a common stomach-restricting device, according to a Nashville Business Journal report.
Louisiana Attorney General Buddy Caldwell has filed a civil action lawsuit against pharmaceutical giant GlaxoSmithKline for wrongfully and illegally marketing, pricing, promoting and selling its diabetes medication, according to a news release from the office of the AG. Rosiglitazone maleate,…
Rey N. Bello, a former neurologist who practiced in West New York and Paramus, N.J., has agreed to permanently surrender his medical license and pay restitution fees to patients’ insurance companies for unnecessary testing and other charges, according to a…
Johnson & Johnson has clashed with the Food and Drug Administration following the FDA's rejection of a sedative containing the drug propofol, according to a Wall Street Journal report.